Skip to main content
Log in

Association of dopamine-based genetic risk score with dynamic low-frequency fluctuations in first-episode drug-naïve schizophrenia

  • Research
  • Published:
Brain Imaging and Behavior Aims and scope Submit manuscript

Abstract

Alterations in dynamic intrinsic brain activity and signaling of neurotransmitters, such as dopamine, have been independently detected in schizophrenia patients. Yet, it remains unclear whether the dopamine genetic risk variants have association with brain intrinsic activity. We aimed to investigate the schizophrenia-specific dynamic amplitude of low frequency fluctuation (dALFF) altered pattern, and its association with dopamine genetic risk score in first-episode drug-naïve schizophrenia (FES). Fifty-two FES and 51 healthy controls were included. A sliding-window method based on the dALFF was adopted to estimate the dynamic alterations in intrinsic brain activity. Subjects were genotyped, and a genetic risk score (GRS), which combined the additive effects of ten risk genotypes from five dopamine-related genes, was calculated. We used the voxel-wise correlation analysis to explore the association of dopamine-GRS with dALFF. FES showed significantly increased dALFF left medial prefrontal cortex and significantly decreased dALFF in the right posterior cingulate cortex compared with healthy controls. Greater dopamine GRS in FES was associated with higher dALFF in the left middle frontal gyrus and left inferior parietal gyrus. Our findings indicate that cumulative dopamine genetic risk is associated with a known imaging phenotype for schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

The datasets used or analyzed during the current study are available from the corresponding author on reasonable request.

References

Download references

Acknowledgements

We thank all the study participants for their efforts. We thank Jijun Wang from Shanghai Mental Health Center for data collection.

Funding

This study was supported in part by China Postdoctoral Science Foundation (Grant/Award No. 2021M692007), Natural Science Foundation (Youth Science Foundation Project) of Shaanxi Province (Grant/Award No. 2022JQ-875).

Author information

Authors and Affiliations

Authors

Contributions

Yafei Kang conceived of the study and drafted the manuscript. Youming Zhang, Kexin Huang and Zhenhong Wang helped to revise the manuscript.

Corresponding authors

Correspondence to Kexin Huang or Zhenhong Wang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval

The study was approved by the Ethics Committee of Shanghai Mental Health Center.

Consent to participate

Before they participated in the study, all subjects provided their informed consent.

Consent to publish

This article has not been published elsewhere in whole or in part. All authors have read and approved the content, and agree to submit for consideration for publication in the journal.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kang, Y., Zhang, Y., Huang, K. et al. Association of dopamine-based genetic risk score with dynamic low-frequency fluctuations in first-episode drug-naïve schizophrenia. Brain Imaging and Behavior 17, 584–594 (2023). https://doi.org/10.1007/s11682-023-00786-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11682-023-00786-2

Keywords

Navigation